These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35389124)

  • 1. Potential plants for inflammatory dysfunction in the SARS-CoV-2 infection.
    Marmitt DJ
    Inflammopharmacology; 2022 Jun; 30(3):749-773. PubMed ID: 35389124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
    Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
    Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
    Giovinazzo G; Gerardi C; Uberti-Foppa C; Lopalco L
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation inhibitory activity of green tea, soybean, and guava extracts during Sars-Cov-2 infection through TNF protein in cytokine storm.
    Priyandoko D; Widowati W; Kusuma HSW; Afifah E; Wijayanti CR; Rizal R; Sholihah IA; Permatasari GW; Ramadhani A; Utomo DH
    Comput Biol Chem; 2023 Aug; 105():107898. PubMed ID: 37247574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
    López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
    Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-mediated liver injury: pathophysiology and mechanisms of disease.
    Choaib A; Issa E; El Choueiry F; Eldin JN; Shbaklo K; Alhajj M; Sawaya RT; Assi G; Nader M; Chatila R; Faour WH
    Inflamm Res; 2023 Feb; 72(2):301-312. PubMed ID: 36539655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
    Torabi-Rahvar M; Rezaei N
    Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody therapy in COVID-19.
    Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hyperinflammation in COVID-19 patients.
    Suberviola B; Cuenca Fito E
    Rev Esp Quimioter; 2022 Oct; 35 Suppl 3(Suppl 3):6-9. PubMed ID: 36285849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19).
    Khongthaw B; Dulta K; Chauhan PK; Kumar V; Ighalo JO
    Inflammopharmacology; 2022 Dec; 30(6):1955-1976. PubMed ID: 36050507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine in the management of Covid-19: With or lieu of evidence.
    Al-Kuraishy HM; Hussien NR; Al-Niemi MS; Al-Gareeb AI
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S127-S132. PubMed ID: 35130235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
    Menegazzi M; Campagnari R; Bertoldi M; Crupi R; Di Paola R; Cuzzocrea S
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.